Journal of Oncology

Note: The following journal information is for reference only. Please check the journal website for updated information prior to submission.

Journal Title

Journal of Oncology

J ONCOL

ISSN / eISSN

1687-8450 / 1687-8469

Aims and Scope

Journal of Oncology is a peer-reviewed, Open Access journal that publishes original research articles, review articles, and clinical studies related to breast cancer, lung cancer, gastrointestinal cancer, skin cancer, head and neck cancer, paediatric oncology, neurooncology as well as genitourinary cancer. The journal provides a multidisciplinary forum for translational and clinical oncology research in the areas of molecular pathology, genomics, diagnosis and therapy, with a specific focus on molecular targeted agents and novel immune therapies.

Subject Area

N/A

CiteScore

3.90

View Trend

CiteScore Ranking

Category	Quartile	Rank
Medicine - Oncology	Q3	#204/366

Web of Science Core Collection

Science Citation Index Expanded (SCIE)	Social Sciences Citation Index (SSCI)
-	-

H-index

Country/Area of Publication

UNITED STATES

Publisher

Hindawi Publishing Corporation

Annual Article Volume

344

Open Access

YES

Contact

ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, ENGLAND, W1T 5HF

Popular journals in the same field
Recent articles

Retracted: IL2RB Is a Prognostic Biomarker Associated with Immune Infiltrates in Pan-Cancer: (2023) Journal of Oncology

Retracted: Yap-Hippo Signaling Activates Mitochondrial Protection and Sustains Breast Cancer Viability under Hypoxic Stress: (2023) Journal of Oncology

Retracted: Development and Validation of a Novel Mitophagy-Related Gene Prognostic Signature for Hepatocellular Carcinoma Based on Immunoscore Classification of Tumor: (2023) Journal of Oncology

Retracted: Mst2 Overexpression Inhibits Thyroid Carcinoma Growth and Metastasis by Disrupting Mitochondrial Fitness and Endoplasmic Reticulum Homeostasis: (2023) Journal of Oncology

Corrigendum to “Function of N6-Methyladenosine Modification in Tumors”: (2023) Nan Zhang, Yuxin Zuo, Yu Peng, Lielian Zuo

Retracted: Preventive Effect of Intensive Nursing Intervention of Deep Vein Thrombosis of Lower Extremities in Elderly Patients with Gastrointestinal Tumors after Surgery: (2023) Journal of Oncology

Retracted: Correlation Between Platelet-Lymphocyte Ratio and Neutrophil-Lymphocyte Ratio in Patients with Uterine Leiomyoma: A Cross-Sectional Study: (2023) Journal of Oncology

Histopathologic Patterns of Ovarian Tumors in Hawassa University Comprehensive Specialized Hospital, Southern Ethiopia: (2023) Tibebu Amare Abena, Fekade Yerakly, Tesfalem Korga

Retracted: Clinical Efficacy of Interventional Chemotherapy Embolization Combined with Monopolar Radiofrequency Ablation on Patients with Liver Cancer: (2023) Journal of Oncology

Retracted: Effect of Cross Theoretical Model of Behaviour Change and Motivation Interview on Self-Management Behaviour: (2023) Journal of Oncology

Verified Reviews

Note: Verified reviews are sourced from across review platforms and social media globally.

Two months for revisions, and acceptance one week after minor revisions. Overall speed is average. The submission system is simple and clear, making it convenient. The journal is also relatively friendly towards Chinese authors. Currently, it has an impact factor of 4.5 and is showing an upward trend.

2022-10-07

Basic research articles, submitted for two days (with editor), sent for external review (under review) and took more than 20 days for the review process, ultimately rejected.

2022-10-24

View All Reviews

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now